1Zaiou M,Arnold KS.Apolipoprotein E-low density lipoprotein receptor interaction:Influences of basic residue and amphipathic-helix organization in the ligand[J].J Lipid Res,2000,41:1087-1095.
2Saito H,Dlmaasekaran P,Baldwin F.Lipid binding-induced confomafional changein human apolipoprotein E:evidence for two lipid-bound states on spherical parficles[J].J Biol Chem,2001,276:40949-40954.
3Nexayanaawami V,Szeto SSW,Ryan RO.Lipid association-indueed N-and C-terminal domain reorganization in human apolipopmtein E3[J].J Biol Chem,2001,276:37853-37860.
4Lurid-Katz S,Wehdi S,Zaiou M,et al.Effects of polymorphism on the microenvlronment of the LDL receptor-bingding region of human apoE[J].J Lipid Rea,2001,42:894-901.
5Raffai RL, Dong LM, Farese RV, et al. Introduction of human apolipoprotein E4 domain interaction' into mouse apolipoprotein[J]. Proc Nail Acad Sci USA,2001,98:11587-11591.
6Fdkke-Sclunidt R, Noniestgaard BG, Agerholm-Larsen B, et al.Context-dependent and invariant asssociations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype [ J ]. J Lipid Res ,2000 ,41 : 1812-1822.
7Mahley RW, Pepin J, Ethan PK, et al. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase:high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype[ J]. J Lipiid Res,2004 ,41 : 129-1301.
8Strittmatter WJ, Hill CB. Molecular biology of apolipoprotein E [ J ]. Curr Opin Lipido1,2002,13 : 119-123.
9Huang Y, Liu XQ, Rail SC, et al. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins[J]. J Biol Chem, 1998,273 : 17483 -17490.
10Srinivasan SR, Ehnholm C, Elkasabany A, et al. Apolipoprotein E polymorphism Modulates the association between obesity and dyslipdemias during young adulthood: the begalusa heart study [ J ]. Metabolism,2001,50:696-702.
8Terra N,Moriguchi Y,Bittencourt L. Apolipoprotein E polymorphism in elderly Japane-se-Brazilian immigrants does not explain the reduced cardiovascular risk factor incidence[J].Genetics and Molecular Research,2011.1975-1985.
9Georgiadou D,Chroni A,Vezeridis A. Biophysical analysis of apoli poprotein E3 variants linked with development of type Ⅲhyperlipoproteinemia[J].PLos One,2011.1-11.
10Harris JD,Evans V,OwenJS. ApoE gene therapy to treat hyperlipidemia and atheroselerosis[J].Current Opinion in Molecular Therapeutics,2006.275-287.
